IP Library Granted Patent US 8,492,414
Granted Patent B2
US 8,492,414 · App. 12/678,767 · Granted Jul 23, 2013

Antibacterial agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,492,414
App. No.
12/678,767
Granted
Jul 23, 2013
Kind
B2
Abstract

Compounds of formula (IA) or (IB) have antibacterial activity: wherein W is ═CH— or ═N—; Ri and R2 are independently selected from hydrogen, fluoro and chloro, provided that Ri and R2 are not each hydrogen when W is ═CH—; n is 0 or 1; X is —O—, —S—, or —CH 2 —; and Q is (i) a phenyl radical, a naphthyl radical, a monocyclic carbocyclic or heteroaryl radical having 3 to 6 ring atoms, or a bicyclic heteroaryl radical having 5 to 10 ring atoms, any of which radicals being optionally substituted; or (ii) an optionally substituted C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl radical, which may optionally be interrupted by —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, —N(CH 2 CH 3 )—, —C—K═Oh or —C(═O)—O—.

Claims (16)

1. A compound which is a substituted thiadiazolylmethoxybenzamide or thiadiazolylmethoxypyridylamide of formula (IA), or a salt thereof:

wherein

W is ═CH— or ═N—;

R 1 and R 2 are independently selected from hydrogen, fluoro and chloro, provided that R 1 and R 2 are not each hydrogen when W is ═CH—;

n is 0 or 1;

X is —O—, —S—, or —CH 2 —; and

Q is (i) a phenyl radical, a naphthyl radical, a monocyclic carbocyclic or heteroaryl radical having 3 to 6 ring atoms, or a bicyclic heteroaryl radical having 5 to 10 ring atoms, any of which radicals being optionally substituted; or (ii) an optionally substituted C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl radical, which may optionally be interrupted by —O—, —S—, —S(O)—, —S(O 2 )—, —NH—, —N(CH 3 )—, —N(CH 2 CH 3 )—, —C(═O)—, or —C(═O)—O—.

2. A compound as claimed in claim 1 wherein W is ═CH—.

3. A compound as claimed in claim 2 wherein R 1 and R 2 are independently fluoro or chloro, or one of R 1 and R 2 is hydrogen while the other is fluoro or chloro.

4. A compound as claimed in claim 1 wherein Q is optionally substituted phenyl.

5. A compound as claimed in claim 1 wherein Q is optionally substituted pyridin-2-yl, or pyridin-3-yl.

6. A compound as claimed in claim 4 wherein any optional substituents in Q are selected from methyl, —OCH 3 , —OCH 2 CH 3 , —CF 3 , —OCF 3 , ethyl, cyclopropyl, oxo, hydroxyl, —F, —Cl, —Br, cyano, acetyl, amino, methylamino, dimethylamino, acetylamino, carbamate, —CONH 2 , nitro, —COOH and —CH 2 OH.

7. A compound as claimed in claim 4 wherein n is 0.

8. A compound selected from the group consisting of:

and salts thereof.

9. A pharmaceutical composition comprising a compound as claimed in claim 1 , together with a pharmaceutically acceptable carrier.

Assignments (4)
SECURITY INTEREST Recorded May 4, 2026
From: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS (NEW JERSEY), INC.; LION ACQUISITION CORPORATION
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 075498/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2014
From: BIOTA SCIENTIFIC MANAGEMENT PTY LTD.; BIOTA EUROPE LIMITED
To: TAXIS PHARMACEUTICALS, INC.
Reel/Frame 033584/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2011
From: BIOTA EUROPE LIMITED
To: BIOTA SCIENTIFIC MANAGEMENT PTY LTD
Reel/Frame 027169/0746 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2010
From: HAYDON, DAVID JOHN; COLLINS, IAN; CZAPLEWSKI, LLOYD GEORGE
To: BIOTA EUROPE LTD
Reel/Frame 024490/0565 →